Precision Biosciences (DTIL) Non Operating Income (2018 - 2026)
Precision Biosciences (DTIL) reported Non Operating Income of -$9.4 million for Q1 2026, down 705.43% year-over-year from $1.5 million in Q1 2025, and down 238.96% quarter-over-quarter from $6.7 million in Q4 2025.
Precision Biosciences (DTIL) Non Operating Income (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Non Operating Income data on file, last reported at -$9.4 million in Q1 2026.
- Non Operating Income for Q1 2026 came in at -$9.4 million, down 705.43% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.4 million (down 124.32% YoY), and the FY2025 annual result was $5.5 million, down 83.38% from the prior year.
- Non Operating Income retreated to -$9.4 million in Q1 2026 per DTIL's latest filing, from $6.7 million in the prior quarter.
- Over five years, Non Operating Income peaked at $12.8 million in Q1 2024 and troughed at -$9.4 million in Q1 2026.
- A 5-year average of $1.2 million and a median of $96000.0 in 2023 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2022 and 2024: Non Operating Income tumbled 6270.83% in 2022, then soared 8861.46% in 2024.
- A 5-year view of Non Operating Income shows it stood at -$7.3 million in 2022, then soared by 119.9% to $1.5 million in 2023, then soared by 387.71% to $7.1 million in 2024, then dropped by 5.08% to $6.7 million in 2025, then tumbled by 238.96% to -$9.4 million in 2026.
- Business Quant data shows DTIL's Non Operating Income at -$9.4 million in Q1 2026, $6.7 million in Q4 2025, and -$1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - | -9.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.37 Mn |
| Dec 31, 2025 | 6.74 Mn |
| Sep 30, 2025 | -1.11 Mn |
| Jun 30, 2025 | -1.64 Mn |
| Mar 31, 2025 | 1.55 Mn |
| Dec 31, 2024 | 7.10 Mn |
| Sep 30, 2024 | 4.85 Mn |
| Jun 30, 2024 | 8.60 Mn |
| Mar 31, 2024 | 12.78 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2023 | 253,000.00 |
| Jun 30, 2023 | 96,000.00 |
| Mar 31, 2023 | -596,000.00 |
| Dec 31, 2022 | -7.32 Mn |
| Sep 30, 2022 | -1.02 Mn |
| Jun 30, 2022 | -1.48 Mn |
| Mar 31, 2022 | -833,000.00 |
| Dec 31, 2021 | 8.43 Mn |
| Sep 30, 2021 | 263,000.00 |
| Jun 30, 2021 | 24,000.00 |